Lithium ALS Trial: Exclusive Breakthrough in Neuroprotection
The groundbreaking lithium ALS trial has emerged as a beacon of hope, exploring lithium’s potential role in neuroprotection for those affected by amyotrophic lateral sclerosis (ALS). With promising preclinical evidence, this trial could redefine therapeutic approaches and offer new possibilities for safeguarding neurons in this challenging disease.








